Get notified when SNTI files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: SNTI Senti Biosciences Holdings, Inc. 8-K

Senti strikes $40M debt deal with largest shareholder requiring 200% repayment, 54.6% stake

Filed May 1, 2026 · Period ending April 27, 2026 · ~1 min read

Key Changes

  • high

    Celadon Partners, Senti's largest shareholder, will acquire 54.6% ownership through $9.7M convertible note purchase, triggering change of control. Second $30M tranche contingent on merger deal with CVRs worth up to $60M tied to SENTI-202 milestones.

  • high

    Notes must be repaid at 200% of principal plus interest if not converted within six months. Event of default triggers redemption at 200% or higher based on stock price formula, creating extreme downside risk if company breaches covenants.

  • high

    Full-ratchet anti-dilution protection means any future stock issuance below $0.6261 automatically lowers conversion price, giving noteholder more shares and severely diluting existing shareholders. This is among the most shareholder-unfriendly terms possible.

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.

Partner

Trade SNTI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify